ANRF well represented at ACR’s Annual Meeting – Arthritis Research

Founded in 1934, the American College of Rheumatology (ACR) is a not-for-profit, professional association committed to advancing the specialty of rheumatology.  Each year, the American College of Rheumatology holds a conference for its more than members which include 7,700 physicians, health professionals and scientists from around the world who work in, research and study rheumatology. A nearly 90-year-old organization, ACR is a not-for-profit, professional organization committed to advancing the specialty of rheumatology.

For the second year in a row, ACR held its annual meeting, Convergence, in the virtual environment. The 2021 meeting was held November 5th through 10th as ACR members hosted research presentations, lectures, Q&A sessions, meetings and attended sessions to learn of the latest research and advancements from their peers and colleagues. Listed below are ANRF Scientific Advisory Board Members and/or researchers and the sessions they led or participated in. In the coming weeks, we will expand on some of these topics, go more in depth on the presentations and share more about  ANRF researchers represented at the conference (poster sessions, abstracts, etc.) in addition to the ones listed.

*Scientific Advisory Board Member

Mary Crow, M.D.*
Hospital for Special Surgery, United States

• Rheumatology Complications of Emerging Viral Infections / SARS-CoV-2
• Speaker: Philip Hench, MD Memorial Lecture: From LE Cell to Interferon: Deconstructing Lupus Pathogenesis
• CH SLE: Gene Expression Profiling & Precision Medicine in Lupus

Betty Diamond, M.D.*
The Feinstein Institutes for Medical Research

• Immune Cell Landscape in Lupus Nephritis, Presented & Moderated Q&A
• CH C&M Tech: The New Histology; Clinical response with pathotype
• CH SLE: What We Learned at ACR Convergence 2021

Hal Hoffman, M.D.*
University California, San Diego

• Understanding and Recognizing Monogenic Autoinflammatory Diseases

Anna Helena Jonsson, M.D., Ph.D.
Brigham and Women’s Hospital

• Q&A Moderator: Molecular Insights from the Accelerating Medicines Partnership (AMP) 2021: Rheumatoid Arthritis
• Q&A Moderator: New Dimensions in Cellular Immunology
• Presenting Author: Granzyme K+ CD8 T Cells Form the Core Population of Inflamed Human Tissue-associated CD8 T-cells (Abstract)
• Q&A Presenter: T Cell Biology & Targets in Autoimmune & Inflammatory Diseases (Abstract)

Michelle Kahlenberg, M.D., Ph.D.* 
University of Michigan

• New Cytokine Targets in Autoimmunity: Interferons in Cutaneous Lupus: Beyond Alpha, Beta and Gamma
• Q&A Presenter: New Cytokine Targets in Autoimmunity

Jason Knight, M.D., Ph.D. 
University of Michigan

• The Many Faces of Cell Death: NETosis in SLE & APS
• Q&A Presenter: Antiphospholipid Syndrome (Abstract)

Anne-Marie Malfait, M.D., Ph.D.*
Rush University
Community Hub (CH) Osteoarthritis(OA): Meet the Presenters: OA & Joint Biology – Basic Science

• CH OA: Lunch with the OA Community
• CH OA: Basic Science Poster Session Tour: Meet the Presenters

Peter Nigrovic, M.D.*
Boston Children’s Hospital

• Early Career: Securing Foundation Funding

Emily Stormoen, CEO
Arthritis National Research Foundation

• Early Career: Securing Foundation Funding

To read more about the ACR’s Annual meeting, go to their website and view the Full Session listings, viewable by select days.